SCHEMBL8001633

SCHEMBL8001633

COc1cccc(N(S(=O)(=O)/C=C/c2ccccc2)S(=O)(=O)/C=C/c2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 7/20 0.50
PPARG P37231 4/20 0.50
LMNA P02545 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAOB P27338 1/20 0.47
RELA Q04206 1/20 0.45
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
BCHE P06276 1/20 0.44
FBP1 P09467 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998940 0.87 NFE2L2 (0.64) NFE2L2RELAFBP1
SCHEMBL8002658 0.87 NFE2L2 (0.45) NFE2L2RELAFBP1
SCHEMBL8002291 0.84 NFE2L2 (0.60) NFE2L2RELAFBP1
SCHEMBL7988658 0.79 PPARG (0.44) PPARGLMNAALDH1A1MAOBMEN1
SCHEMBL7988653 0.78 MAOB (0.41) NFE2L2PPARGLMNAALDH1A1MAOB
SCHEMBL8001632 0.78 MAPT (0.48) NFE2L2PPARGLMNAMAOBMMP1
SCHEMBL7998337 0.77 NFE2L2 (0.62) NFE2L2RELAFBP1
SCHEMBL8002290 0.75 MAOB (0.47) NFE2L2MAOBMMP1MMP2MMP9
SCHEMBL1122564 0.74 NFE2L2 (0.56) NFE2L2PPARGLMNAALDH1A1RELA
SCHEMBL1122565 0.74 NFE2L2 (0.56) NFE2L2PPARGLMNAALDH1A1RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009120783-A1 HIGH AFFINITY INHIBITORS OF HEPATITIS C VIRUS NS3/4A PROTEASE THE JOHNS HOPKINS UNIVERSITY (US) 2009-10-01 WO disclosed